LOS ANGELES, Feb. 1 /PRNewswire-FirstCall/ -- Sunnylife Global, Inc. (OTC:SNYL) announced today it has accepted a notice of withdrawal by Bioceuticals, Inc. from the Memorandum of Understanding signed in October 2005. In a letter received by Sunnylife Global the principals of Bioceuticals said that, although the proposal for merger by Sunnylife provided them a strong business opportunity, the joint venture is premature in their business plan. "We are hopeful that Bioceuticals will be in a position in the not too distant future to again consider a business alliance with Sunnylife," said Richard Lo, Chairman. About Sunnylife Global, Inc. Sunnylife Global, Inc. has developed a Health Care Management System (HCMS) in conjunction with the Chinese Government Authorities that will result in delivering superior quality health care management to its members. The Company is in multiple joint-venture agreements with the World Friendship Hospital Group to renovate and revitalize China's older hospital facilities in order to meet the current International standard. Sunnylife has developed the HCMS to meet that standard and is planning to launch in the very near future. In addition, the Company has patented natural, environmentally safe and economically affordable products which it plans to introduce to Chinese customers through seven different joint venture companies in China. Sunnylife represents an organization staffed with professional experts in product research, quality acceptance testing, and market development for service to China and the global markets. For more information, please visit http://www.sunnylifeglobal.com/. Safe Harbor Statement The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. All forward-looking statements attributable to the Company, or persons acting for the Company, are expressly qualified in their entirety by these cautionary statements. Contact: Investor Relations Fran Daniels, President Financial Sciences of America (310) 278-4413 DATASOURCE: Sunnylife Global, Inc. CONTACT: Investor Relations, Fran Daniels, President of Financial Sciences of America, +1-310-278-4413, , for Sunnylife Global, Inc. Web site: http://www.sunnylifeglobal.com/

Copyright